Dapafyzin-M 10/500 Tablet ER
Marketer
Care Formulation Labs Pvt Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Dapafyzin-M 10/500 Tablet ER
Dapafyzin-M 10/500 Extended-Release tablets combine two medications to manage type 2 diabetes. This dual-action therapy effectively lowers elevated blood glucose, mitigating the risk of serious diabetic complications and potentially preventing cardiovascular disease. Dapafyzin-M 10/500 ER can be taken with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician; discontinuation requires medical consultation, as abrupt cessation may elevate blood sugar, increasing the risk of severe complications such as kidney failure and vision loss. This medication is a component of a comprehensive diabetes management plan, encompassing a doctor-recommended diet, exercise regimen, and weight management strategy. Frequently reported side effects include pharyngitis, rhinorrhea, nasal congestion, cephalalgia, nausea, emesis, and diarrhea. Adequate hydration helps prevent dehydration. Genital yeast infections may occur; meticulous hygiene can minimize this risk. Prior to initiating treatment, disclose any renal or hepatic impairment, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical advice before use. Limit alcohol consumption, as it may potentiate adverse effects. Regular blood glucose monitoring is crucial during treatment.
Primary Ingredients of Dapafyzin-M 10/500 Tablet ER
The provided text is "undefined". Therefore, no rewriting is possible.
Uses of Dapafyzin-M 10/500 Tablet ER
Managing type 2 diabetes
Major Benefits of Dapafyzin-M 10/500 Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Dapafyzin-M 10/500 Tablet ER with a meal.
Common Side effects of Dapafyzin-M 10/500 Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Dapafyzin-M 10/500 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Dapafyzin-M 10/500 Extended-Release tablet should be taken with a meal.
How Dapafyzin-M 10/500 Tablet ER works:
Dapagliflozin and Metformin, combined as Dapafyzin-M 10/500 ER tablets, offer enhanced blood glucose management. Dapagliflozin facilitates urinary glucose excretion, while Metformin reduces hepatic glucose production, slows intestinal glucose uptake, and improves insulin responsiveness. This dual-action approach optimizes blood sugar control.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Dapafyzin-M 10/500 Tablet ER is hazardous.
PregnancyCONSULT YOUR DOCTOR
The extended-release Dapafyzin-M 10/500 tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dapafyzin-M 10/500 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with severely low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Dapafyzin-M 10/500 Extended-Release tablets cautiously. Dosage modification may be necessary; physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should use Dapafyzin-M 10/500 ER tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Dapafyzin-M 10/500 Tablet ER :
Should you forget a Dapafyzin-M 10/500 Tablet ER dose, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapafyzin-M 10/500 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |



